Rat P-Cadherin quantitates rat P-Cadherin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat P-Cadherin.
Accession number
Ai385538; Cadh3; cadhérine 15, cadhérine M (myotubule); cadhérine 3; Cadhérine 3, type 1, P-cadhérine (placentaire); cadhérine-3; CADP; Protéine d’adhérence dépendante du calcium, placentaire ; CDH15 ; CDH3 ; CDHP ; HJMD; PCAD; P-cadhérine; cadhérine placentaire; cadhérine placentaire; Cadhérine spécifique à la RPE
Dose range
0.041 to 10 ng/ml
Sensitivity of the dosage
0.041 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Rat P-Cadherin quantitates rat P-Cadherin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat P-Cadherin.
Rat P-Cadherin quantitates rat P-Cadherin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat P-Cadherin.
P-cadherin, also known as cadherin-3, is a type 1 cadherin protein that belongs to the cadherin superfamily. Type 1 cadherins are single-pass transmembrane proteins that have 5 extracellular cadherin repeats and an intracellular domain that binds p120-catenine and beta-catenine. Cadherins are calcium-dependent cell adhesion glycoproteins responsible for several processes, including wound development, wound healing, cell-to-cell signaling, cell growth, and differentiation. P-cadherin is expressed in human foetal structures and adult tissues such as the basal layer of the epidermis, breast, prostate, lovarian, cervix, hair follicle, and corneal endothelium. P-cadherin expression has also been reported on embryonic stem cells, normal breast gland stem cells, and hair follicles. Overexpression of P-cadherin has been associated with poor prognosis in the carcinomas of the breast, prostate, lovarian, colon and stomach. Mutations in CDH3 are associated with congestive hyporichosis with juvenile macular dystrophy.
Sensitivity
Sensitivity of dosage: 0.041 ng/ml.
Measurement range
Dose range: 0.041 to 10 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: P-cadherin.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).